These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors. Rabban JT; Zaloudek CJ; Shekitka KM; Tavassoli FA Am J Surg Pathol; 2005 Oct; 29(10):1348-55. PubMed ID: 16160478 [TBL] [Abstract][Full Text] [Related]
3. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297 [TBL] [Abstract][Full Text] [Related]
4. ALK-1-positive inflammatory myofibroblastic tumor of the thyroid complicated by Hashimoto's thyroiditis: report of a rare case and a literature review. Li CF; Wu XL; Wang JJ; Wang K; Zhang SY; Huang JJ; Hu HZ; Zheng H Diagn Pathol; 2020 May; 15(1):58. PubMed ID: 32430041 [TBL] [Abstract][Full Text] [Related]
5. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505 [TBL] [Abstract][Full Text] [Related]
6. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts. Qiu X; Montgomery E; Sun B Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254 [TBL] [Abstract][Full Text] [Related]
7. Mesenteric inflammatory myofibroblastic tumors. Chaudhary P Ann Gastroenterol; 2015; 28(1):49-54. PubMed ID: 25608706 [TBL] [Abstract][Full Text] [Related]
8. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Coffin CM; Hornick JL; Fletcher CD Am J Surg Pathol; 2007 Apr; 31(4):509-20. PubMed ID: 17414097 [TBL] [Abstract][Full Text] [Related]
9. Recurrent infantile inflammatory myofibroblastic tumor of mesentery--Case report and review of imaging findings. Gupta A; Sharma S; Mittal A; Barwad A; Rastogi S Radiol Case Rep; 2021 Mar; 16(3):504-510. PubMed ID: 33363692 [TBL] [Abstract][Full Text] [Related]
10. Inflammatory myofibroblastic tumor of the mesentery with a SQSTM1::ALK fusion responding to alectinib. Sunga CGG; Higgins MS; Ricciotti RW; Liu YJ; Cranmer LD Cancer Rep (Hoboken); 2023 Mar; 6(3):e1792. PubMed ID: 36754839 [TBL] [Abstract][Full Text] [Related]
11. Inflammatory Myofibroblastic Tumor of the Testis in a Patient With Cecal Carcinoma. Chandramouli R; Sowmya YS; Raghava Ks A; Gochhait D; Jagadesan P Cureus; 2023 Sep; 15(9):e44573. PubMed ID: 37662511 [TBL] [Abstract][Full Text] [Related]
12. A recurrent inflammatory myofibroblastic tumor patient with two novel Xu X; Li L; Zhang Y; Meng F; Xie H; Duan R Transl Cancer Res; 2022 Sep; 11(9):3379-3384. PubMed ID: 36237256 [TBL] [Abstract][Full Text] [Related]
13. Inflammatory myofibroblastic tumor of the urinary bladder with FN1‑ALK gene fusion: A case report. Son SM; Woo CG; Lee OJ; Kim YJ; Lee HC Oncol Lett; 2023 Jun; 25(6):227. PubMed ID: 37153035 [TBL] [Abstract][Full Text] [Related]
14. Case Report: Clinical response to anaplastic lymphoma kinase inhibitor-based targeted therapy in uterine inflammatory myofibroblastic tumor harboring Zhao T; Zhang X; Liu X; Ren M; Cheng Y; Wang J; Luo Z Front Oncol; 2023; 13():1147974. PubMed ID: 37035208 [TBL] [Abstract][Full Text] [Related]
15. Inflammatory myofibroblastic tumors of the central nervous system that express anaplastic lymphoma kinase have a high recurrence rate. Denis DJ; Elayoubi K; Weil AG; Berthelet F; Bojanowski MW Surg Neurol Int; 2013; 4():70. PubMed ID: 23776756 [TBL] [Abstract][Full Text] [Related]
16. Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases. Li XQ; Hisaoka M; Shi DR; Zhu XZ; Hashimoto H Hum Pathol; 2004 Jun; 35(6):711-21. PubMed ID: 15188137 [TBL] [Abstract][Full Text] [Related]
17. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases. Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797 [TBL] [Abstract][Full Text] [Related]
18. PD-L1 expression and CD8+ tumor-infiltrating lymphocytes are associated with ALK rearrangement and clinicopathological features in inflammatory myofibroblastic tumors. Cha YJ; Shim HS Oncotarget; 2017 Oct; 8(52):89465-89474. PubMed ID: 29163763 [TBL] [Abstract][Full Text] [Related]
19. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Cook JR; Dehner LP; Collins MH; Ma Z; Morris SW; Coffin CM; Hill DA Am J Surg Pathol; 2001 Nov; 25(11):1364-71. PubMed ID: 11684952 [TBL] [Abstract][Full Text] [Related]
20. An isolated inflammatory myofibroblastic tumor of adrenal gland. Al Sannaa G; Wimmer JL; Ayala AG; Ro JY Ann Diagn Pathol; 2016 Dec; 25():33-36. PubMed ID: 27806843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]